arrow
M

Murat Iskar

guardant health, inc
H指数:45
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pipeline Olympics: continuable benchmarking of computational workflows for DNA methylation sequencing data against an experimental gold standard

Pipeline Olympics:针对DNA甲基化测序数据,基于实验金标准的可延续性计算工作流基准测试

2025-10-280
OAAI
Integrative multi-omics reveals a regulatory and exhausted T-cell landscape in CLL and identifies galectin-9 as an immunotherapy target

整合多组学揭示CLL中调节性及耗竭性T细胞景观,并鉴定出galectin-9作为免疫治疗靶点

2025-08-070
OA
Integration of transcriptomics, proteomics and loss-of-function screening reveals WEE1 as a target for combination with dasatinib against proneural glioblastoma
2024-11-010
OA
Proteomic, Metabolomic, and Fatty Acid Profiling of Small Extracellular Vesicles from Glioblastoma Stem-Like Cells and Their Role in Tumor Heterogeneity

胶质母细胞瘤干样细胞小胞外囊泡的蛋白质组学、代谢组学和脂肪酸谱及其在肿瘤异质性中的作用

2024-01-1110
OAAI
Proteogenomics refines the molecular classification of chronic lymphocytic leukemia
2022-10-2020
OAAI
A synergistic interaction between HDAC- and PARP inhibitors in childhood tumors with chromothripsis
2022-04-286
OA
Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity
IMMUNITY
IF26.3
2021-12-0172
OAAI
Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations

原发性松果体实质肿瘤的分子亚组揭示了与临床参数和遗传改变相关的不同亚型

2019-11-2549
OAAI
Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell Infiltration
2019-11-0176
OAAI
Linking aberrant chromatin features in chronic lymphocytic leukemia to transcription factor networks
2019-05-2234
OAAI
Tumor-derived exosomes modulate PD-L1 expression in monocytes

肿瘤来源的外泌体调节单核细胞中的PD-L1表达

2017-07-21266
OAAI